Medicina (Kaunas):脱细胞牛腹膜敷料治疗烧伤可改善患者的生活质量

2022-07-26 MedSci原创 MedSci原创

根据世界卫生组织的统计,烧伤每年造成18万人死亡。即使是不致命的烧伤病例也会对患者的健康造成很大的危害,因为会发生感染和挛缩。同种和异种生物工程结构常被用作治疗烧伤的伤口涂层,并已显示出其有效性。

根据世界卫生组织的统计,烧伤每年造成18万人死亡。即使是不致命的烧伤病例也会对患者的健康造成很大的危害,因为会发生感染和挛缩。同种和异种生物工程结构常被用作治疗烧伤的伤口涂层,并已显示出其有效性。然而,这种敷料的缺点是成本很高。这个问题对于烧伤发病率最高的发展中国家尤其具有挑战性。近日,发表于Medicina (Kaunas)的一项随机临床试验来开发并临床测试了一种基于脱细胞牛腹膜(DBP)作为伤口涂层治疗烧伤的疗效。

研究人员考虑了以下变量:住院天数、换药次数、换药时的疼痛程度以及随访检查时的伤口状况。

结果,研究共纳入68名参与者,测试组31人,对照组37人,其中47人是男性(对照组27人,测试组20人),21人是女性(对照组10人,测试组11人)。分析结果发现,接受DBP治疗的患者疼痛程度较轻,换药次数较少。然而,与对照组相比,住院天数和伤口愈合情况未能显示出统计学上的显著差异。

综上所述,在给定的研究中,DBP通过减少疼痛和更换敷料的次数显示出改善患者生活质量的疗效。然而,当把这项研究与其他动物来源的伤口覆盖物的研究进行比较时,在参数上存在一些差异和限制。因此,该结果需要进一步研究,以提高数据的可比性。鉴于上述情况,预计DBP将成为发展中国家治疗烧伤的一种廉价而有效的方法。

原始出处:

Berik Tuleubayev, et al., Therapeutic Treatment of 2A Grade Burns with Decellularized Bovine Peritoneum as a Xenograft: Multicenter Randomized Clinical Trial. Medicina (Kaunas). 2022 Jun 17;58(6):819. doi: 10.3390/medicina58060819.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1634649, encodeId=f1a61634649dc, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Tue Mar 07 04:39:48 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859282, encodeId=45fa18592829f, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 21 08:39:48 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774078, encodeId=52ea1e74078af, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Aug 08 03:39:48 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234845, encodeId=b33a123484594, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=ms5000000644045955, createdTime=Tue Jul 26 11:52:53 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611671, encodeId=244316116e11c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623879, encodeId=a59616238e9e8, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2023-03-07 guozhenyu
  2. [GetPortalCommentsPageByObjectIdResponse(id=1634649, encodeId=f1a61634649dc, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Tue Mar 07 04:39:48 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859282, encodeId=45fa18592829f, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 21 08:39:48 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774078, encodeId=52ea1e74078af, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Aug 08 03:39:48 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234845, encodeId=b33a123484594, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=ms5000000644045955, createdTime=Tue Jul 26 11:52:53 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611671, encodeId=244316116e11c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623879, encodeId=a59616238e9e8, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2023-06-21 jeanqiuqiu
  3. [GetPortalCommentsPageByObjectIdResponse(id=1634649, encodeId=f1a61634649dc, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Tue Mar 07 04:39:48 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859282, encodeId=45fa18592829f, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 21 08:39:48 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774078, encodeId=52ea1e74078af, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Aug 08 03:39:48 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234845, encodeId=b33a123484594, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=ms5000000644045955, createdTime=Tue Jul 26 11:52:53 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611671, encodeId=244316116e11c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623879, encodeId=a59616238e9e8, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-08-08 kalseyzl
  4. [GetPortalCommentsPageByObjectIdResponse(id=1634649, encodeId=f1a61634649dc, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Tue Mar 07 04:39:48 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859282, encodeId=45fa18592829f, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 21 08:39:48 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774078, encodeId=52ea1e74078af, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Aug 08 03:39:48 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234845, encodeId=b33a123484594, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=ms5000000644045955, createdTime=Tue Jul 26 11:52:53 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611671, encodeId=244316116e11c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623879, encodeId=a59616238e9e8, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-26 ms5000000644045955

    不错,学习了。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1634649, encodeId=f1a61634649dc, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Tue Mar 07 04:39:48 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859282, encodeId=45fa18592829f, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 21 08:39:48 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774078, encodeId=52ea1e74078af, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Aug 08 03:39:48 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234845, encodeId=b33a123484594, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=ms5000000644045955, createdTime=Tue Jul 26 11:52:53 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611671, encodeId=244316116e11c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623879, encodeId=a59616238e9e8, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1634649, encodeId=f1a61634649dc, content=<a href='/topic/show?id=91f85e855f2' target=_blank style='color:#2F92EE;'>#敷料#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57855, encryptionId=91f85e855f2, topicName=敷料)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=362922222105, createdName=guozhenyu, createdTime=Tue Mar 07 04:39:48 CST 2023, time=2023-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1859282, encodeId=45fa18592829f, content=<a href='/topic/show?id=e0a9593596' target=_blank style='color:#2F92EE;'>#DIC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5935, encryptionId=e0a9593596, topicName=DIC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Wed Jun 21 08:39:48 CST 2023, time=2023-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1774078, encodeId=52ea1e74078af, content=<a href='/topic/show?id=5f014e1852' target=_blank style='color:#2F92EE;'>#CIN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4718, encryptionId=5f014e1852, topicName=CIN)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a038523631, createdName=kalseyzl, createdTime=Mon Aug 08 03:39:48 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234845, encodeId=b33a123484594, content=不错,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4dfa6526517, createdName=ms5000000644045955, createdTime=Tue Jul 26 11:52:53 CST 2022, time=2022-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1611671, encodeId=244316116e11c, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623879, encodeId=a59616238e9e8, content=<a href='/topic/show?id=16ba8564526' target=_blank style='color:#2F92EE;'>#腹膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85645, encryptionId=16ba8564526, topicName=腹膜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93e220615097, createdName=xuyong530, createdTime=Mon Jul 25 11:39:48 CST 2022, time=2022-07-25, status=1, ipAttribution=)]
    2022-07-25 xuyong530

相关资讯

J Invest Dermatol:烧伤诱导的局部和全身免疫反应

烧伤创伤通常会诱发免疫系统的过度反应,称为全身炎症反应综合征(SIRS),这项系统综述包括247项动物研究,显示了创伤组织和循环中涉及即时和长期效应的14种不同免疫细胞类型的烧伤后反应。

疤痕增生影响不仅仅是颜值,还有这些

瘢痕影响的不仅仅是颜值,还有可能影响机体正常的功能甚至可能恶变。

Burns:早期蛋白C的激活在烧伤的严重程度、炎症及预后中的研究

本文阐述了早期蛋白C的激活系统的动态概况,这可能会促进我们对烧伤全身病理生理学的深入了解,从而达到诊断、预测和治疗的目的。

男子瞒着烧伤父亲“割皮救父”

6月12日,李红星66岁的父亲李圈在做饭时,煤气罐意外爆炸,全身70%被烧伤。

Mil Med:战时烧伤伤员局部治疗新方法研究

烧伤是战场上常见的伤病。鉴于恶劣的环境,对受伤军人进行外科清创往往是不可行的。这项研究试图确定最好的商业上可用的现成(OTS)疗法,具有现场部署的潜力,以改善烧伤受伤士兵的长期野战护理(PFC)。

Int Wound J:可吸收明胶海绵复合聚氨酯膜在骨、肌腱外露创面真皮重建中的新应用

由于创伤、糖尿病和皮肤肿瘤切除造成的全层皮肤缺陷正成为一个重大的健康问题,在这项研究中证明了一种止血材料,可吸收明胶海绵(AGS),与聚氨酯薄膜相结合,作为一种低成本重建手术方法的有效性。